Skip to content

Pilot Study on the Effectiveness of Novel Peripherally Inserted Central Catheter (PICC) Securement Dressing in Preventing PICC Dislodgement

Pilot Study on the Effectiveness of Novel Peripherally Inserted Central Catheter (PICC) Securement Dressing in Preventing PICC Dislodgement

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07817732
Enrollment
67
Registered
2026-09-14
Start date
2024-03-21
Completion date
2025-09-25
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient With PICC Lines, PICC

Keywords

PICC line, Pilot study, Sleeve cover

Brief summary

Evidence regarding clinical effectiveness and acceptability of PICC sleeves remain limited. Few randomised controlled trials have evaluated PICC sleeves in routine hospital practice, and there is limited evidence regarding their feasibility, safety and influence on line condition. This pilot randomised controlled trial aims to evaluate the feasibility, safety, and user experience of a protective PICC sleeve among hospitalised patients with PICCs.

Interventions

OTHERNovel PICC Sleeve Cover

The novel PICC sleeve cover would be applied on the intervention group in addition to standard PICC securement practices.

Sponsors

Changi General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Pilot single-centre, parallel-group randomised controlled trial.

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients receiving PICC placement for various medical conditions

Exclusion criteria

* Patients with known allergies to materials in the PICC sleeve * Patients contraindicated for PICC placement * Patients who are aggressive and/or restless * Patients whose skin condition is unsuitable for CHG gel dressing application (e.g. skin with eczema plaques, bullous pemphigoid) * Patients who have no mental capacity to give consent

Design outcomes

Primary

MeasureTime frameDescription
Participant Recruitment Rate16 monthsNumber of participants recruited over the recruitment period

Secondary

MeasureTime frameDescription
Intervention AdherenceFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Percentage of participants who were compliant to wearing the PICC sleeve cover
Retention of Study Participants across 3 Time-pointsFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Number of study participants across 3 time-points (2 days after PICC insertion, 14 days after PICC insertion or upon removal, whichever earlier, and 7 days after discharge from hospital) presented as a percentage of the original number of study participants in each arm
Completeness of Data CollectedFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Percentage of data collected over the ideal number of data to be collected
Number of Adverse EventsFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Percentage of participants suffering from adverse events over the total number of participants
Patient-Reported Dislodgement RiskFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Mean score of all participants rating their perceived dislodgement risk on a self-designed questionnaire from 1 (strongly disagree) to 5 (strongly agree) in each study arm.
Patient-Reported Comfort LevelFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Mean score of all participants rating their perceived comfort level on a self-designed questionnaire from 1 (strongly disagree) to 5 (strongly agree) in each study arm.
Patient-Reported Visibility LevelFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Mean score of all participants rating their perceived visibility level on a self-designed questionnaire from 1 (strongly disagree) to 5 (strongly agree) in each study arm. The visibility level refers to the degree the PICC dressing is exposed to the onlookers and how that may affect their own self-image.
Patient-Reported User-friendlinessFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Mean score of all participants rating their perceived user-friendliness of the PICC dressing on a self-designed questionnaire from 1 (strongly disagree) to 5 (strongly agree) in each study arm.
Patient-Reported Acceptability OutcomeFrom enrolment to 7 days after discharge or upon removal, whichever earlier.The mean of the mean scores for patient-reported dislodgement risk, comfort level, visibility level and user-friendliness.
Staff-Reported Dislodgement RiskFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Mean score of all participants rating their patients' perceived dislodgement risk on a self-designed questionnaire from 1 (strongly disagree) to 5 (strongly agree) in each study arm.
Staff-Reported Comfort LevelFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Mean score of all participants rating their patients' perceived comfort level on a self-designed questionnaire from 1 (strongly disagree) to 5 (strongly agree) in each study arm.
Staff-Reported Visibility LevelFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Mean score of all participants rating their patient's perceived visibility level on a self-designed questionnaire from 1 (strongly disagree) to 5 (strongly agree) in each study arm. The visibility level refers to the degree the PICC dressing is exposed to the onlookers and how that may affect their own self-image.
Staff-Reported User-friendlinessFrom enrolment to 7 days after discharge or upon removal, whichever earlier.Mean score of all participants rating their patient's perceived user-friendliness of the PICC dressing on a self-designed questionnaire from 1 (strongly disagree) to 5 (strongly agree) in each study arm.
Staff-Reported Acceptability OutcomeFrom enrolment to 7 days after discharge or upon removal, whichever earlier.The mean of the mean scores for staff-reported dislodgement risk, comfort level, visibility level and user-friendliness.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026